| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Figure 2. VAS-total scores at baseline and at each treatment cycle for subjects randomized to receive placebo, paroxetine CR 12.5 mg, or paroxetine CR 25 mg.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |